Marie D. Burdick

Q: What Schools Are Affiliated With Marie D. Burdick

Marie D. Burdick is affiliated with the following schools: Yale University, University of Michigan, University of Florida, University of California, Los Angeles, University of Virginia, University of Pennsylvania

Marie D. Burdick's AcademicInfluence.com Rankings

Marie D. Burdick

Biology

#10471

World Rank

#13804

Historical Rank

Cell Biology

#495

World Rank

#507

Historical Rank

Genetics

#1107

World Rank

#1206

Historical Rank

Molecular Biology

#1525

World Rank

#1552

Historical Rank

biology Degrees

Download Badge

Biology

Marie D. Burdick's Degrees

PhD Molecular Biology Stanford University

Why Is Marie D. Burdick Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Marie D. Burdick's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) (1995) (1250)
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. (2004) (1069)
CXC chemokines in angiogenesis. (2005) (856)
Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. (1996) (804)
Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. (1992) (643)
The CXC Chemokine Receptor 2, CXCR2, Is the Putative Receptor for ELR+ CXC Chemokine-Induced Angiogenic Activity1 (2000) (588)
Involvement of endothelial PECAM-1/CD31 in angiogenesis. (1997) (525)
The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. (2003) (480)
Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. (2002) (452)
Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. (1996) (440)
Cutting Edge: IFN-Inducible ELR− CXC Chemokines Display Defensin-Like Antimicrobial Activity1 (2001) (405)
Cancer CXC chemokine networks and tumour angiogenesis. (2006) (403)
Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. (1995) (400)
Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma (1994) (392)
Regulation of neutrophil-derived chemokine expression by IL-10. (1994) (386)
Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases (1996) (385)
The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. (1997) (383)
Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. (1994) (320)
CXC chemokines in angiogenesis (2000) (305)
Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. (1995) (304)
Epidermal Growth Factor and Hypoxia-induced Expression of CXC Chemokine Receptor 4 on Non-small Cell Lung Cancer Cells Is Regulated by the Phosphatidylinositol 3-Kinase/PTEN/AKT/Mammalian Target of Rapamycin Signaling Pathway and Activation of Hypoxia Inducible Factor-1α* (2005) (298)
Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. (1995) (297)
Depletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer1 (2004) (295)
MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. (1998) (284)
Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. (1998) (282)
Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. (2001) (270)
Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. (1993) (266)
Neutrophil recruitment and resistance to urinary tract infection. (1999) (265)
The Association between Mortality Rates and Decreased Concentrations of Interleukin-10 and Interleukin-1 Receptor Antagonist in the Lung Fluids of Patients with the Adult Respiratory Distress Syndrome (1996) (264)
IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. (1999) (264)
Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein. (1995) (261)
Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. (1999) (260)
Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. (2007) (251)
Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. (1997) (251)
BRAK/CXCL14 Is a Potent Inhibitor of Angiogenesis and a Chemotactic Factor for Immature Dendritic Cells (2004) (240)
Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. (1996) (239)
The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. (1995) (239)
Critical Role for CXCR3 Chemokine Biology in the Pathogenesis of Bronchiolitis Obliterans Syndrome1 (2002) (236)
Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis (1997) (233)
Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis. (1994) (230)
Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. (1996) (229)
Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis. (2002) (222)
Expression and regulation of human neutrophil-derived macrophage inflammatory protein 1 alpha (1993) (218)
Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression (1997) (218)
IL-8 is an angiogenic factor in human coronary atherectomy tissue. (2000) (217)
Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. (1999) (211)
Secondary Lymphoid Tissue Chemokine Mediates T Cell-Dependent Antitumor Responses In Vivo1 (2000) (208)
Differentiation of Human Circulating Fibrocytes as Mediated by Transforming Growth Factor-β and Peroxisome Proliferator-activated Receptor γ* (2007) (197)
The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis (2009) (197)
Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions. (1995) (197)
Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. (1996) (191)
Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. (1995) (181)
Stromal Derived Factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis (2006) (179)
The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. (1996) (177)
Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis. (2009) (177)
The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma (2000) (175)
Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis. (2000) (174)
Macrophage inflammatory protein-1 alpha expression in interstitial lung disease. (1993) (173)
CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. (2005) (169)
Platelets Release CXCL4L1, a Nonallelic Variant of the Chemokine Platelet Factor-4/CXCL4 and Potent Inhibitor of Angiogenesis (2004) (169)
MCP-1 expression by rat type II alveolar epithelial cells in primary culture. (1993) (168)
The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat (1996) (166)
Production and function of murine macrophage inflammatory protein-1 alpha in bleomycin-induced lung injury. (1994) (164)
Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. (1993) (163)
Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint. (2001) (161)
Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. (1998) (161)
A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). (1992) (161)
Differential Expression of CC Chemokines and the CCR5 Receptor in the Pancreas Is Associated with Progression to Type I Diabetes1 (2000) (161)
The Role of the Th2 CC Chemokine Ligand CCL17 in Pulmonary Fibrosis1 (2004) (158)
Growth-related gene product alpha. A chemotactic cytokine for neutrophils in rheumatoid arthritis. (1995) (156)
Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines (2000) (155)
Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-gamma in mouse macrophages. (1998) (152)
Circulating Progenitor Epithelial Cells Traffic via CXCR4/CXCL12 in Response to Airway Injury1 (2006) (151)
The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis. (2000) (149)
Monokine Induced by IFN-γ Is a Dominant Factor Directing T Cells into Murine Cardiac Allografts During Acute Rejection1 (2001) (148)
Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. (2005) (147)
High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. (2006) (147)
Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer. (2011) (147)
Regulation of neutrophil-derived IL-8: the role of prostaglandin E2, dexamethasone, and IL-4. (1993) (139)
The Role of CXCR2/CXCR2 Ligand Biological Axis in Renal Cell Carcinoma1 (2005) (139)
The Role of the CC Chemokine, RANTES, in Acute Lung Allograft Rejection1 (2000) (137)
CXC‐chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer (2009) (137)
CXCR2 Is Critical to Hyperoxia-Induced Lung Injury1 (2004) (137)
Cyclooxygenase-2-Dependent Expression of Angiogenic CXC Chemokines ENA-78/CXC Ligand (CXCL) 5 and Interleukin-8/CXCL8 in Human Non-Small Cell Lung Cancer (2004) (137)
ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis. (2001) (136)
Role of CXCL9/CXCR3 Chemokine Biology during Pathogenesis of Acute Lung Allograft Rejection 1 (2003) (133)
Enhanced tumor‐forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth‐regulated cytokine β and γ proteins (1997) (132)
Inhibition of interferon γ induced interleukin 12 production: A potential mechanism for the anti-inflammatory activities of tumor necrosis factor (1998) (131)
Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis. (2006) (130)
Production of interleukin-10 by human bronchogenic carcinoma. (1994) (130)
IL-12 attenuates bleomycin-induced pulmonary fibrosis. (2001) (130)
Characterization of human fibrocytes as circulating adipocyte progenitors and the formation of human adipose tissue in SCID mice (2005) (130)
Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. (2007) (129)
Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome. (2005) (126)
Neovascularization during venous thrombosis organization: a preliminary study. (1999) (126)
Macrophage inflammatory protein-2 is required for neutrophil passage across the epithelial barrier of the infected urinary tract. (1999) (125)
Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity (2015) (123)
IL-7 inhibits fibroblast TGF-β production and signaling in pulmonary fibrosis (2002) (122)
Severe combined immunodeficiency mouse and human psoriatic skin chimeras. Validation of a new animal model. (1995) (120)
Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma. (2005) (117)
Enhanced pulmonary inflammation in organ donors following fatal non-traumatic brain injury (1999) (116)
Compartmentalized expression of RANTES in a murine model of endotoxemia. (1995) (113)
Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-1 alpha during monocyte-endothelial cell interactions. (1994) (112)
CXCR3/CXCR3 Ligand Biological Axis Impairs RENCA Tumor Growth by a Mechanism of Immunoangiostasis1 (2006) (112)
Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. (1997) (110)
Pleural mesothelial cell expression of C-C (monocyte chemotactic peptide) and C-X-C (interleukin 8) chemokines. (1995) (109)
Chemokine and inflammatory cytokine changes during chronic wound healing (1997) (108)
Early NK Cell-Derived IFN-γ Is Essential to Host Defense in Neutropenic Invasive Aspergillosis1 (2009) (107)
Macrophage inflammatory protein-1alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. (1997) (107)
Identification and Partial Characterization of a Variant of Human CXCR3 Generated by Posttranscriptional Exon Skipping1 (2004) (107)
CXC Chemokines: Angiogenesis, Immunoangiostasis, and Metastases in Lung Cancer (2004) (106)
Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis. (2007) (103)
Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer. (2005) (101)
The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis. (1999) (100)
Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3. (2011) (99)
Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis (2004) (99)
IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. (1998) (97)
CXCR2/CXCR2 Ligand Biology during Lung Transplant Ischemia-Reperfusion Injury1 (2005) (95)
Inflammatory and Procoagulant Mediator Interactions in an Experimental Baboon Model of Venous Thrombosis (1993) (93)
The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis. (2009) (89)
IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis. (2002) (87)
IL-13 Is Pivotal in the Fibro-Obliterative Process of Bronchiolitis Obliterans Syndrome1 (2007) (86)
SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10 (2003) (85)
PROLIFERATIVE EFFECTS OF CXC CHEMOKINES IN RAT HEPATOCYTES IN VITRO AND IN VIVO (1998) (84)
Monocyte chemotactic protein expression during schistosome egg granuloma formation. Sequence of production, localization, contribution, and regulation. (1995) (83)
Non-Small Cell Lung Cancer Cells (2013) (80)
Gene expression of macrophage inflammatory protein-1 alpha from human blood monocytes and alveolar macrophages is inhibited by interleukin-4. (1993) (80)
Interferon gamma modulates the expression of neutrophil-derived chemokines. (1995) (77)
Induction of apoptosis by particulate matter: role of TNF-α and MAPK. (1998) (77)
Macrophage Inflammatory Protein-Iβ: A C-C Chemokine in Osteoarthritis (1995) (77)
P-selectin and TNF inhibition reduce venous thrombosis inflammation. (1996) (72)
The role of MIG/CXCL9 in cardiac allograft vasculopathy. (2002) (71)
Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells. (1999) (71)
Elevated Serum Levels of the CXCR3 Chemokine ITAC Are Associated With the Development of Transplant Coronary Artery Disease (2003) (70)
The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA. (1992) (68)
Stimulus and cell-specific expression of C-X-C and C-C chemokines by pulmonary stromal cell populations. (1995) (68)
Expression and regulation of human pulmonary fibroblast-derived monocyte chemotactic peptide-1. (1992) (67)
Improved survival in tumor-bearing SCID mice treated with interferon-γ-inducible protein 10 (IP-10/CXCL10) (2001) (66)
Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia. (2017) (65)
Imbalance in the Expression of CXC Chemokines Correlates with Bronchoalveolar Lavage Fluid Angiogenic Activity and Procollagen Levels in Acute Respiratory Distress Syndrome1 (2002) (63)
Neutrophil chemokines in bronchoalveolar lavage fluid and leukocyte-conditioned medium from nonsmokers and smokers. (1998) (62)
Mast cells produce ENA‐78, which can function as a potent neutrophil chemoattractant during allergic airway inflammation (1998) (61)
The murine CC chemokine, 6C-kine, inhibits tumor growth and angiogenesis in a human lung cancer SCID mouse model (2001) (60)
Neutropenia Enhances Lung Dendritic Cell Recruitment in Response to Aspergillus via a Cytokine-to-Chemokine Amplification Loop (2010) (60)
Production of IL-8 and monocyte chemotactic peptide-1 by peripheral blood monocytes. Disparate responses to phytohemagglutinin and lipopolysaccharide. (1994) (60)
IL-7 up-regulates the expression of IL-8 from resting and stimulated human blood monocytes. (1992) (59)
Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. (1998) (57)
Interferons Induce CXCR3-cognate Chemokine Production by Human Metastatic Melanoma (2010) (56)
CXCR4, but not CXCR7, Discriminates Metastatic Behavior in Non–Small Cell Lung Cancer Cells (2013) (56)
Neutrophils are the initial cell type identified in deep venous thrombosis induced vein wall inflammation. (1996) (55)
Human circulating fibrocytes have the capacity to differentiate osteoblasts and chondrocytes. (2010) (54)
Cytokine production in IgG‐mediated red cell incompatibility (1993) (53)
Expression and participation of eotaxin during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granuloma formation. (1998) (52)
Keratinocyte growth factor improves repair in the injured tracheal epithelium. (2007) (51)
Chemokine response to febrile urinary tract infection. (2005) (51)
Neutrophils Mediate Maturation and Efflux of Lung Dendritic Cells in Response to Aspergillus fumigatus Germ Tubes (2012) (51)
Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker. (2011) (51)
Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients. (2002) (50)
Expression and regulation of macrophage inflammatory protein-1 alpha by murine alveolar and peritoneal macrophages. (1994) (50)
Celecoxib Decreases Ki-67 Proliferative Index in Active Smokers (2006) (47)
Induction of apoptosis by particulate matter: role of TNF-alpha and MAPK. (1998) (46)
The ratio of ELR+ to ELR− CXC chemokines affects the lung and liver injury following hepatic ischemia/reperfusion in the rat (2000) (46)
Expression and regulation of human alveolar macrophage-derived interleukin-1 receptor antagonist. (1992) (44)
Adenosine A(2B) receptor deficiency promotes host defenses against gram-negative bacterial pneumonia. (2012) (44)
Critical role for CXCR 2 and CXCR 2 ligands during the pathogenesis of ventilator-induced lung injury (2002) (43)
Antimicrobial Effects of Interferon-Inducible CXC Chemokines against Bacillus anthracis Spores and Bacilli (2009) (43)
Interferon-Inducible CXC Chemokines Directly Contribute to Host Defense against Inhalational Anthrax in a Murine Model of Infection (2010) (43)
Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis. A compartmental analysis. (1995) (42)
CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer (2009) (42)
Number, activation, and differentiation of circulating fibrocytes correlate with asthma severity. (2016) (42)
The SDF-1/CXCL 12/CXCR4 biological axis in non-small cell lung cancer metastases. (2004) (40)
Plasma Chemokine Levels Are Associated with the Presence and Extent of Angiographic Coronary Collaterals in Chronic Ischemic Heart Disease (2011) (39)
The role of CXCR2/CXCR2 ligands in acute lung injury. (2005) (39)
CXC chemokines in angiogenesis relevant to chronic fibroproliferation. (2005) (38)
Overexpression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome. (2001) (38)
Fimbrial lectins influence the chemokine repertoire in the urinary tract mucosa. (2007) (37)
The production of interleukin-1 receptor antagonist by human bronchogenic carcinoma. (1993) (37)
CXCR2 is critical for dsRNA-induced lung injury: relevance to viral lung infection (2005) (35)
Enhanced CXCL1 production and angiogenesis in adenosine‐mediated lung disease (2007) (35)
Characterization of the production of monocyte chemoattractant protein-1 and IL-8 in an allogeneic immune response. (1993) (34)
Expression of CXCR3 on Mononuclear Cells and CXCR3 Ligands in Patients With Metastatic Renal Cell Carcinoma in Response to Systemic IL-2 Therapy (2007) (33)
CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis (2009) (33)
Monocyte chemoattractant protein production in red cell incompatibility (1994) (32)
CXCR2/CXCR2 Ligand Biological Axis Impairs Alveologenesis During dsRNA-Induced Lung Inflammation in Mice (2005) (32)
Pilot analysis of the plasma metabolite profiles associated with emphysematous Chronic Obstructive Pulmonary Disease phenotype. (2011) (30)
Macrophage inflammatory protein-1 beta: a C-C chemokine in osteoarthritis. (1995) (30)
Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome. (2014) (30)
Role of Leukotriene A4 Hydrolase Aminopeptidase in the Pathogenesis of Emphysema (2014) (29)
Heterogeneity of lung mononuclear phagocytes during pneumonia: contribution of chemokine receptors. (2013) (28)
HEPATIC INFLAMMATION FOLLOWING 70% HEPATECTOMY MAY BE RELATED TO UP‐REGULATION OF EPITHELIAL NEUTROPHIL ACTIVATING PROTEIN‐78 (1996) (28)
Dose-dependent Effect of Statin Therapy on Circulating CXCL12 Levels in Patients with Hyperlipidemia (2012) (27)
Specific ELISAs for the detection of human macrophage inflammatory protein-1 alpha and beta. (1993) (27)
The production of chemotactic cytokines in an allogeneic response. The role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3. (1993) (27)
Role of LTB₄ in the pathogenesis of elastase-induced murine pulmonary emphysema. (2010) (26)
Interleukin-1 receptor antagonist expression in sarcoidosis. (1993) (26)
The Role of Fibrocytes in Sickle Cell Lung Disease (2012) (25)
Plasma CXCL12 Levels as a Predictor of Future Stroke (2012) (25)
Interleukin-1 receptor antagonist blocks chemokine production in the mixed lymphocyte reaction. (1993) (24)
In vitro production of interleukin‐1 receptor antagonist in IgG‐ mediated red cell incompatibility (1994) (21)
Leukotriene A4 Hydrolase Activation and Leukotriene B4 Production by Eosinophils in Severe Asthma (2019) (21)
Escherichia coli Pyruvate Dehydrogenase Complex Is an Important Component of CXCL10-Mediated Antimicrobial Activity (2015) (20)
The chemokine receptor, CXCR2, mediates the tumorigenic effects of ELR+ CXC chemokines. (2004) (18)
Interleukin-10 regulates quartz-induced pulmonary inflammation in rats. (1998) (18)
VCAM-1 influences lymphocyte proliferation and cytokine production during mixed lymphocyte responses. (1994) (15)
Interleukin-10 regulates quartz-induced pulmonary inflammation in rats. (1998) (14)
Expression of interleukin-8 by lipopolysaccharide-stimulated bone marrow-derived mononuclear cells (1992) (14)
Monocyte Chemotactic Protein Expression during Schistosome EggGranuloma Formation (1995) (14)
Inhibition of interferon g induced interleukin 12 production : A potential mechanism for the anti-inflammatory activities of tumor necrosis factor (1998) (13)
In vitro transendothelial migration of blood T lymphocytes from HIV‐infected individuals (1997) (13)
M-CSF Mediates Host Defense during Bacterial Pneumonia by Promoting the Survival of Lung and Liver Mononuclear Phagocytes (2016) (12)
POST-ISCHEMIC SHUNT FOLLOWING HEPATIC POST ISCHEMIA/REPERFUSION DOES NOT AFFECT TISSUE CHEMOKINE LEVELS OR TISSUE INJURY (1996) (12)
Role of CXCR 2 / CXCR 2 ligands in vascular remodeling during bronchiolitis obliterans syndrome (2005) (11)
Elevated Serum Levels of the CXCR 3 Chemokine ITAC Are Associated With the Development of Transplant Coronary Artery Disease (2003) (10)
Effect of Modifier Structure on the Activation of Leukotriene A4 Hydrolase Aminopeptidase Activity. (2019) (8)
Circulating fibrocytes as biomarkers of impaired lung function in adults with sickle cell disease. (2017) (8)
Use of Immunodeficient Mice for the Evaluation of CXC Chemokines in the Regulation of Tumor-associated Angiogenesis. (1999) (8)
CXCR 2 Is Critical to Hyperoxia-Induced Lung Injury 1 (2004) (8)
The Stromal Derived Factor‐1/CXCL12‐CXC Chemokine Receptor 4 Biological Axis in Renal Cell Carcinoma Metastasis (2006) (7)
Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease (2020) (7)
Circulating fibrocytes as predictors of adverse events in unstable angina. (2016) (7)
Liver inflammation in a mouse model of Th1 hepatitis despite the absence of invariant NKT cells or the Th1 chemokine receptors CXCR3 and CCR5 (2012) (6)
Regulation of monocyte-derived interleukin 1 receptor antagonist by cisplatinum. (1995) (5)
Circulating fibrocytes traffic to the lung in murine acute lung injury and predict outcomes in human acute respiratory distress syndrome: a pilot study (2020) (5)
CXC chemokines regulate angiogenic activity in acute lung injury. (1999) (5)
Cyclooxygenase-2 dependent expression of angiogenic CXC chemokines, ENA-78/CXCL5 and IL-8/CXCL8, in human non-small cell lung cancer (2004) (5)
Expression and Regulation of Human Neutrophil-derived Macrophage Inflammatory Protein (1993) (5)
CCL 17 in Pulmonary Fibrosis The Role of the Th 2 CC Chemokine Ligand (2004) (5)
Regulation of chemokine production by the oxidative metabolism of L-arginine in a human mixed lymphocyte reaction. (1994) (4)
Chapter 2.6 – CXC Chemokines in Angiogenesis (2002) (4)
Pancreatic Cancer (1998) (4)
Angiogenesis, Immunoangiostasis, and Metastases in Lung Cancer (2004) (4)
Chemoattractant Protein-1 in Rheumatoid Arthritis (1992) (3)
4 EPITHELIAL NEUTROPHIL ACTIVATING PROTEIN (ENA-78) MEDIATES HEPATIC ISCHEMIA-REPERFUSION (I/R) INDUCED LIVER AND LUNG INJURY (1995) (3)
Rejection during Pathogenesis of Acute Lung Allograft Role of CXCL 9 / CXCR 3 Chemokine Biology (2003) (3)
The presence of pro-fibrotic cytokines correlate with outcome in patients with idiopathic pulmonary fibrosis (1996) (3)
190 CIRCULATING PROGENITOR EPITHELIAL CELLS TRAFFIC VIA CXCR4/CXCL12 IN RESPONSE TO AIRWAY INJURY. (2006) (3)
Interferon-γ Stimulates Monocyte Chemotactic Protein-1 Expression by Monocytes (1994) (3)
Neutrophil-derived TNF drives fungal acute lung injury in chronic granulomatous disease. (2021) (3)
HEPATIC INFLAMMATION FOLLOWING 70% HEPATECTOMY MAY BE RELATED TO UPREGULATION OF ENA‐78.: 154 (1996) (3)
Interleukin-12 Attenuates Pulmonary Fibrosis via Induction of Interferon-γ (2001) (3)
CXC Chemokines in Cancer (2005) (2)
Increased circulating fibrocytes are associated with higher reticulocyte percent in children with sickle cell anemia (2016) (2)
Preventing Angiogenesis Melanoma and Lung Carcinoma Growth and Metastasis by Platelet Factor-4 Variant Chemokine CXCL 4 L 1 Inhibits (2007) (2)
Fibrocytes in Human Pulmonary Fibrosis: Double-Blind Placebo-Controlled Crossover Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (2017) (2)
Elevated Levels of Monocyte Chemoattractant Protein-1 Are Associated With Bronchiolitis Obliterans Syndrome, a Fibrotic Disease of the Small Airways (2001) (2)
CXC-Chemokines/CXCR2 mediate a novel pathway of angiogenesis in pancreatic cancer (2007) (1)
Metabolite Profiling Of Plasma From Emphysematous COPD Patients (2012) (1)
Systemic Fibrocyte Levels and Keloid Expression of the Chemoattractant CXCL12 Are Upregulated Compared With Patients With Normal Scar (2021) (1)
Measurement of chemokines at the protein level in tissue. (2003) (1)
(platelet factor-4 variant) are mediated by CXCR3 Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (2012) (1)
Elevation in Peripheral Fibrocyte Counts Correlates With Presence of Interstitial Lung Disease in Patients With Hermansky-Pudlak Syndrome (2013) (1)
Syndrome Process of Bronchiolitis Obliterans IL-13 Is Pivotal in the Fibro-Obliterative (2006) (1)
Differential effects of IFN-α and IFN-γ on upregulation of IFN-inducible chemokines CXCL9, CXCL10 and CXCL11. (2008) (1)
EFFECT OF GENDER ON THE TREATMENT RESPONSES TO RAPAMYCIN ON THE PROGRESSION OF EMPHYSEMA IN CIGARETTE SMOKE-EXPOSED MICE (2020) (1)
Aspergillus utilizes extracellular heme as an iron source during invasive pneumonia, driving infection severity. (2022) (1)
PMNʼs ARE THE INITIAL CELL TYPE IN VENOUS THROMBOSIS INDUCED VEIN WALL INFLAMMATION (1996) (1)
Mast cell-derived ena-78 functions as a potent neutrophil chemoattractant during allergic airway inflammation (1996) (1)
Protein in Rat Adjuvant-Induced Arthritis Neutrophil-Activating Peptide-78-Like The Role of an Epithelial (1999) (1)
Mobilization of Circulating Progenitor Epithelial Cells with Keratinocyte Growth Factor Aids in Airway Repair. (2006) (1)
ActivityChemokines Display Defensin-Like Antimicrobial CXC - Cutting Edge: IFN-Inducible ELR (2001) (1)
Erratum: BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells (Cancer Research (November 15, 2004) 64, 1 (8262-8270)) (2004) (0)
169 INCREASED MIG/CXCL9 AND IP-10/CXCL10 IN VIRUS-INDUCED LUNG INFLAMMATION…A PRELUDE TO BRONCHOPULMONARY DYSPLASIA? (2004) (0)
222; HEPATIC ENA‐78 RELEASE FOLLOWING HEPATIC ISCHEMIA‐REPERFUSION (I/R), and FROM CULTURED HEPATOCYTES (1994) (0)
Inhibition of Angiogenesis Bleomycin-Induced Pulmonary Fibrosis Via-Inducible Protein-10 Attenuates γ IFN - (1999) (0)
Circulating fibrocytes traffic to the lung in murine acute lung injury and predict outcomes in human acute respiratory distress syndrome: a pilot study (2020) (0)
The angiostatic CXC chemokines, IP-10 and MIG are reduced during the pathogenesis of bleomycin-induced pulmonary fibrosis (1997) (0)
Tumorigenesis and Neoplastic Progression Overexpression of CXCL 5 Is Associated With Poor Survival in Patients With Pancreatic Cancer (2011) (0)
Distress Syndrome Procollagen Levels in Acute Respiratory Lavage Fluid Angiogenic Activity and Bronchoalveolar Chemokines Correlates with Imbalance in the Expression of CXC (2002) (0)
Expression of CXC Chemokines during IL-2 Therapy Correlates with Response in Metastatic Renal Cell Carcinoma (2004) (0)
BRAINSTEM DEATH NEUTROPHIL CHEMOTACTIC ACTIVITY IN THE DONOR LUNG BY INCREASED INTRA-ALVEOLAR C-X-C CHEMOKINE EXPRESSION. (1999) (0)
Transplant Ischemia-Reperfusion Injury CXCR 2 / CXCR 2 Ligand Biology during Lung (2005) (0)
CXCR4+ Cytokeratin5+ CD45+ Progenitor Epithelial Cells Are Present in Bone Marrow and Are Recruited during Airway Epithelial Injury. (2004) (0)
Inflammation and Thrombosis IL-10 Regulates Thrombus-Induced Vein Wall (2013) (0)
Regulation of Fibrocyte‐derived CXC Chemokine Receptor 4 (CXCR4) by Hypoxia and the Phosphatidylinositol 3‐Kinase (PI‐3‐K)/Mammalian Target of Rapamycin (mTOR) Signaling Pathway (2007) (0)
Role of the tumor microenvironment in the promotion of alveolar epithelial neoplasia induced by oncogenic KRAS. (2006) (0)
Interferon-Y inducible protein 10 (IP-10) inhibits tumor growth of non-small cell lung cancer (NSCLC) (1996) (0)
Inhibit ion o f Inter leukin 8 Attenuates (2003) (0)
Biology of LTA4 Hydrolase in the Elastase-Induced Murine Pulmonary Emphysema. (2009) (0)
in Mice Klebsiella pneumoniae Enhances Resistance to Lung-Specific Transgenic Expression of KC (1998) (0)
Circulating fibrocyte levels correlate with infarct size in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention (2021) (0)
Interferon-y-inducib le Prote in 10 ( IP-10 ) Is an Angiostat ic Factor That Inhibits (2003) (0)
Fibrosis Attenuates Bleomycin-Induced Pulmonary Macrophage Inflammatory Protein-2 , Neutralization of the CXC Chemokine (1999) (0)
Prostaolandin E2 augments the production of two pro-inflammatory chemokines (ENA-78 and GRO-α) (1996) (0)
Intercellular Adhesion Molecule-l Mediates the Expression of Monocyte-Derived MIP-la During Monocyte-Endothelial Cell Interactions (2002) (0)
CXCR4, Not CXCR7, Mediates Hypoxia-Induced Migration Of Non-Small Cell Lung Cancer (NSCLC) Cells And Tumor Development By NSCLC Cells (2011) (0)
Tumor associated macrophages and CC chemokines in lung cancer (1998) (0)
Responses In Vivo Mediates T Cell-Dependent Antitumor Secondary Lymphoid Tissue Chemokine (2017) (0)
DiabetesAssociated with Progression to Type I and the CCR5 Receptor in the Pancreas Is Differential Expression of CC Chemokines (2000) (0)
Allografts During Acute Rejection Factor Directing T Cells into Murine Cardiac Is a Dominant γ Monokine Induced by IFN - (2001) (0)
Structural determinants of LTA4H aminopeptidase activation (2018) (0)
CXCR4, Not CXCR7, Is An Important Mediator For Hypoxia-induced Migration Of Non-small Cell Lung Cancer (NSCLC) Cells (2010) (0)
Mononuclear Myeloid Cells In Host Defense Against Klebsiella Pneumonia -- Essential Role Of M-CSF And CCR2 (2011) (0)
THE RATIO OF ELR- TO ELR+ CXC CHEMOKINES AFFECTS NEUTROPHIL-DEPENDENT LUNG AND LIVER INJURY FOLLOWING HEPATIC ISCHEMIA/REPERFUSION (1999) (0)
Mechanism of Immunoangiostasis Impairs RENCA Tumor Growth by a CXCR3/CXCR3 Ligand Biological Axis (2006) (0)
Differentiation of human circulating fibrocytes into chondrocytes and osteoblasts (2008) (0)
Differential Gene Expression and Pathway Enrichment May Explain Female Resistance to Emphysema in Murine Models of COPD (2021) (0)
γ-Interferon may decrease hepatic and pulmonary inflammation and injury following hepatic ischemia/reperfusion (1998) (0)
Circulating Fibrocyte Levels in Various Inflammatory Pulmonary Disease States (2020) (0)
Elevated levels of the CXCR3 chemokine ligand itac is associated with the development of severe transplant coronary artery disease in humans (2003) (0)
LTB4 Receptor 1 As A Protective Gene In The Murine Modeling Of Pulmonary Emphysema (2010) (0)
Integrated oral poster session 1: Wed 2/7 5:00 pmOncology VIII: Clinical outcomeP80: CXC chemokines are elevated in the serum and tumors of pancreatic cancer patients (2007) (0)
Higher Levels of Circulating Fibrocytes Are Associated with Lower Oxygen Saturation in Adults with Sickle Cell Disease (2014) (0)
Pulmonary arterial hypertension [PAH] is associated with increased capillary blood proangiogenic C-X-C chemokines (2002) (0)
A Blood-to-Liver CXCL12 Concentration Gradient Parallels Increasing Fibrocytes and Liver Fibrosis in a Murine Model: 478 (2012) (0)
Cytokine-to-Chemokine Amplification Loop via a Aspergillus Recruitment in Response to Neutropenia Enhances Lung Dendritic Cell (2010) (0)
The candidate tumor suppressor gene ING4 is down‐regulated in human lung cancer and correlates with an increase in ELR+ CXC chemokines (2006) (0)
Role Of CXCR3 And Its Ligands In Neutropenic Invasive Pulmonary Aspergillosis (2011) (0)
Granuloma Formation Schistosomal ( Type 2 ) Antigen-Elicited During Mycobacterial ( Type 1 ) and Expression and Participation of Eotaxin (1998) (0)
Selectively targeting LTA4H aminopeptidase activity for the development of novel anti-inflammatory drugs (2017) (0)
Sirolimus suppresses circulating fibrocytes in idiopathic pulmonary fibrosis in a randomized controlled crossover trial. (2023) (0)
Interleukin-1 receptor antagonist is elevated in lung transplant recipients with obliterative bronchiolitis (1996) (0)
Airway Injury Traffic via CXCR4/CXCL12 in Response to Circulating Progenitor Epithelial Cells (2006) (0)
Circulating Activated And Differentiated Fibrocytes In Severe Asthma (2012) (0)
Factor-4/CXCL4 and Potent Inhibitor of Angiogenesis Platelets Release CXCL4L1, a Nonallelic Variant of the Chemokine Platelet (2011) (0)
The effect of modifier structure on the activation of leukotriene A4 hydrolase aminopeptidase activity. (2019) (0)
Neutrophilic alveolitis in obliterattve bronchiolitis after lung transplantation: role of interleukin-8 (1996) (0)
X-ray crystal structure determination of LTA4H:4MDM:PGP analogue complex and characterization of the aminopeptidase enzyme mechanism (2019) (0)
Exploration of Quantitative Emphysematous Responses to Cigarette Smoke Exposure Among Two Different Murine Strains Stratified by Gender (2020) (0)
The effect of intra-pulmonary CXC-chemokines in the donor lung on early graft function after lung transplantation (1999) (0)
S2007 CXCL5[ENA-78] Is Overexpressed in Pancreatic Cancer and Mediates Pancreatic Cancer-Derived Angiogenesis (2009) (0)
Circulating Cytokeratin 5+ Progenitor Epithelial Cells Also Express Other Progenitor Cell Markers and Are Necessary for Normal Airway Repair. (2005) (0)
Antagonist by Human Bronchogenic Carcinoma (2007) (0)
The Role of Melanoma Growth-Stimulatory Activity in Melanoma Tumorigenesis and Angiogenesis (1999) (0)
357: Augmentation of Type 1 immune response cytokines/chemokines is associated with pulmonary arterial hypertension (2007) (0)
CXCR4, but notCXCR7,DiscriminatesMetastatic Behavior in Non–Small Cell Lung Cancer Cells (2014) (0)
CXC chemokine regulation of prostate cancer angiogenesis (1998) (0)
Absence Of The Adenosine A2B Receptor Protects Against Klebsiella Pneumonia By Enhancing Neutrophil Bactericidal Activity (2011) (0)
Acute Lung Allograft Rejection The Role of the CC Chemokine, RANTES, in (2000) (0)
Activite antimicrobienne des chimiokines elr- inductibles par interferon (2003) (0)
738: Pilot Study to Determine the Incidence of Circulating Renal Cell Carcinoma (RCC) Cells in Patients with Metastatic Disease Before and after Treatment with IL-2 Therapy (2006) (0)
1357 BCG BLADDER TUMOR SUPPRESSION IS MEDIATED BY CXCR3 (2011) (0)
Increased Circulating Activated Fibrocytes Are Associated With Severe Asthma (2011) (0)
Tract Epithelial Barrier of the Infected Urinary Required for Neutrophil Passage Across the Macrophage Inflammatory Protein-2 Is (1999) (0)
CIRCULATING FIBROCYTE LEVEL AS A MARKER OF MYOCARDIAL FIBROSIS FOLLOWING ACUTE ST ELEVATION MYOCARDIAL INFARCTION (2020) (0)
Fibrocytes contribute to the increased levels of fibrosis observed in Th2 pulmonary granulomas in TLR9-/- mice (54.18) (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Marie D. Burdick?

Marie D. Burdick is affiliated with the following schools:

Marie D. Burdick's Academic­Influence.com Rankings

Marie D. Burdick's Degrees

Why Is Marie D. Burdick Influential?

Marie D. Burdick's Published Works

Published Works

What Schools Are Affiliated With Marie D. Burdick?

Marie D. Burdick's AcademicInfluence.com Rankings